These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9885782)

  • 21. Cardiac noradrenergic function one year following cardiac transplantation.
    Rundquist B; Eisenhofer G; Dakak NA; Elam M; Waagstein F; Friberg P
    Blood Press; 1993 Dec; 2(4):252-61. PubMed ID: 8173693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients.
    Repo-Tiihonen E; Eloranta A; Hallikainen T; Tiihonen J
    Neuropsychobiology; 2005; 51(4):173-6. PubMed ID: 15870506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases.
    Goldstein DS; Castillo G; Sullivan P; Sharabi Y
    J Pharmacol Exp Ther; 2021 Nov; 379(3):253-259. PubMed ID: 34503991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics.
    Grillo RW; Ottoni GL; Leke R; Souza DO; Portela LV; Lara DR
    J Psychiatr Res; 2007; 41(1-2):31-5. PubMed ID: 16546213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the frequency of nerve stimulation on the metabolism of 3H-norepinephrine released from the perfused cat spleen: differences observed during and after the period of stimulation.
    Dubocovich ML; Langer SZ
    J Pharmacol Exp Ther; 1976 Jul; 198(1):83-101. PubMed ID: 933013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine and noradrenergic function: support for a novel hypothesis for superior efficacy.
    Breier A
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():122-5. PubMed ID: 7961555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual phases of functional change in norepinephrine transporter in cultured bovine adrenal medullary cells by long-term treatment with clozapine.
    Yoshimura R; Yanagihara N; Hara K; Nakamura J; Toyohira Y; Ueno S; Izumi F
    J Neurochem; 2001 May; 77(4):1018-26. PubMed ID: 11359867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Peripheral Catecholamine Responses to Acute Stress in Young Adult and Aged F-344 Rats.
    McCarty R; Pacak K; Goldstein DS; Eisenhofer G
    Stress; 1997 Dec; 2(2):113-122. PubMed ID: 9787260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of plasma levels of catechols in the evaluation of sympathoadrenomedullary function.
    Goldstein DS; Eisenhofer G; Garty M; Folio CJ; Stull R; Brush JE; Sax FL; Keiser HR; Kopin IJ
    Am J Hypertens; 1989 Mar; 2(3 Pt 2):133S-139S. PubMed ID: 2493793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients.
    Hinze-Selch D; Becker EW; Stein GM; Berg PA; Mullington J; Holsboer F; Pollmächer T
    Neuropsychopharmacology; 1998 Aug; 19(2):114-22. PubMed ID: 9629565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neurotoxic compound N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) depletes endogenous norepinephrine and enhances release of [3H]norepinephrine from rat cortical slices.
    Landa ME; Rubio MC; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):131-6. PubMed ID: 6491970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norepinephrine release and vascular response elicited by nerve stimulation in rats with chronic neurogenic hypertension.
    Granata AR; Enero MA; Krieger EM; Langer SZ
    J Pharmacol Exp Ther; 1983 Oct; 227(1):187-93. PubMed ID: 6312017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action.
    Breier A; Elman I; Goldstein DS
    Adv Pharmacol; 1998; 42():785-8. PubMed ID: 9328015
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients.
    Wong JO; Leung SP; Mak T; Ng RM; Chan KT; Hon-Kee Cheung H; Choi WK; Lai J; Wai-Kiu Tsang A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):251-64. PubMed ID: 16316716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormalities in systemic norepinephrine kinetics in human congestive heart failure.
    Davis D; Baily R; Zelis R
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E760-6. PubMed ID: 3377075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of desipramine on norepinephrine metabolism in humans: interaction with aging.
    Stromberg JS; Linares OA; Supiano MA; Smith MJ; Foster AH; Halter JB
    Am J Physiol; 1991 Dec; 261(6 Pt 2):R1484-90. PubMed ID: 1750571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma clearance, metabolism, and tissue accumulation of 3H-labeled catecholamines in trout.
    Nekvasil NP; Olson KR
    Am J Physiol; 1986 Mar; 250(3 Pt 2):R519-25. PubMed ID: 3953858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia.
    Davidson M; Kahn RS; Stern RG; Hirschowitz J; Apter S; Knott P; Davis KL
    Psychiatry Res; 1993 Feb; 46(2):151-63. PubMed ID: 8483974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia.
    Elman I; Rott D; Green AI; Langleben DD; Lukas SE; Goldstein DS; Breier A
    Psychopharmacology (Berl); 2004 Nov; 176(3-4):369-75. PubMed ID: 15179540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative efficiencies of plasma catechol levels and ratios for neonatal diagnosis of menkes disease.
    Goldstein DS; Holmes CS; Kaler SG
    Neurochem Res; 2009 Aug; 34(8):1464-8. PubMed ID: 19234788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.